SCHEMBL21761373

SCHEMBL21761373

Cc1[nH]c2nccc(Cl)c2c1-c1ccc2c(c1)N(C(=O)OC(C)(C)C)CCO2

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.41
▸ BTK Q06187 1/20 0.41
▸ ESR1 P03372 1/20 0.37
▸ PDE3B Q13370 2/20 0.37
▸ PDE3A Q14432 2/20 0.37
▸ FGFR4 P22455 2/20 0.37
▸ USP30 Q70CQ3 2/20 0.36
▸ TBK1 Q9UHD2 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ MAPT P10636 4/20 0.35
▸ THRB P10828 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CSNK2A1 P68400 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ ALK Q9UM73 1/20 0.34
▸ IMPDH2 P12268 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21760533 0.91 EGFR (0.40) EGFRBTKESR1PDE3BPDE3A
SCHEMBL21753048 0.91 EGFR (0.40) EGFRBTKESR1PDE3BPDE3A
SCHEMBL29700774 0.91 EGFR (0.40) EGFRBTKESR1PDE3BPDE3A
SCHEMBL21761292 0.89 EGFR (0.39) EGFRBTKESR1PDE3BPDE3A
SCHEMBL24699679 0.84 FGFR4 (0.50) EGFRBTKFGFR4JAK3ALK
SCHEMBL21747850 0.78 PDE3B (0.39) EGFRPDE3BPDE3AFGFR4USP30
SCHEMBL21753141 0.77 CHRM4 (0.37) FGFR4USP30TBK1ALK
SCHEMBL29700791 0.77 CHRM4 (0.37) FGFR4USP30TBK1ALK
SCHEMBL21753139 0.76 BRD4 (0.38) BTKTBK1ALK
SCHEMBL29700787 0.76 BRD4 (0.38) BTKTBK1ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3807274-B1 4-SUBSTITUTED PYRROLO[2,3-B]PYRIDINE AS ERBB MODULATORS USEFUL FOR TREATING CANCER LEAD DISCOVERY CENTER GMBH (DE) 2022-07-27 — — EP disclosed
EP-3613738-A1 4-SUBSTITUTED PYRROLO[2,3-B]PYRIDINE AS ERBB MODULATORS USEFUL FOR TREATING CANCER Lead Discovery Center GmbH (DE) 2020-02-26 — — EP disclosed
Send feedback